Literature DB >> 6321957

Construction and expression of a recombinant DNA gene encoding a polyomavirus middle-size tumor antigen with the carboxyl terminus of the vesicular stomatitis virus glycoprotein G.

D Templeton, A Voronova, W Eckhart.   

Abstract

We constructed a molecular clone encoding the N-terminal 379 amino acids of the polyomavirus middle-size tumor antigen, followed by the C-terminal 60 amino acids of the vesicular stomatitis virus glycoprotein G. This hybrid gene contained the coding region for the C-terminal hydrophobic membrane-spanning domain of the G protein in place of the C-terminal hydrophobic domain of the middle-size tumor antigen. The hybrid gene was expressed in COS-1 cells under the control of the simian virus 40 late promoter. The hybrid protein was located in cell membranes and was associated with a tyrosine-specific protein kinase activity, as was the middle-size tumor antigen. Plasmids encoding the hybrid protein failed to transform mouse NIH 3T3 or rat F2408 cells.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6321957      PMCID: PMC368693          DOI: 10.1128/mcb.4.2.282-289.1984

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  32 in total

1.  New classes of viable deletion mutants in the early region of polyoma virus.

Authors:  B E Griffin; C Maddock
Journal:  J Virol       Date:  1979-09       Impact factor: 5.103

2.  Construction and analysis of viable deletion mutants of polyoma virus.

Authors:  G Magnusson; P Berg
Journal:  J Virol       Date:  1979-11       Impact factor: 5.103

3.  The nucleotide sequence and genome organization of the polyoma early region: extensive nucleotide and amino acid homology with SV40.

Authors:  T Friedmann; A Esty; P LaPorte; P Deininger
Journal:  Cell       Date:  1979-07       Impact factor: 41.582

4.  Protein kinase activity associated with polyoma virus middle T antigen in vitro.

Authors:  A E Smith; R Smith; B Griffin; M Fried
Journal:  Cell       Date:  1979-12       Impact factor: 41.582

5.  Tumor antigens induced by nontransforming mutants of polyoma virus.

Authors:  J Silver; B Schaffhausen; T Benjamin
Journal:  Cell       Date:  1978-10       Impact factor: 41.582

6.  Evidence that the phosphorylation of tyrosine is essential for cellular transformation by Rous sarcoma virus.

Authors:  B M Sefton; T Hunter; K Beemon; W Eckhart
Journal:  Cell       Date:  1980-07       Impact factor: 41.582

7.  DNA-mediated transfer of the adenine phosphoribosyltransferase locus into mammalian cells.

Authors:  M Wigler; A Pellicer; S Silverstein; R Axel; G Urlaub; L Chasin
Journal:  Proc Natl Acad Sci U S A       Date:  1979-03       Impact factor: 11.205

8.  An activity phosphorylating tyrosine in polyoma T antigen immunoprecipitates.

Authors:  W Eckhart; M A Hutchinson; T Hunter
Journal:  Cell       Date:  1979-12       Impact factor: 41.582

9.  Chicken ovalbumin contains an internal signal sequence.

Authors:  V R Lingappa; J R Lingappa; G Blobel
Journal:  Nature       Date:  1979-09-13       Impact factor: 49.962

10.  Virus-specific proteins in the plasma membrane of cells lytically infected or transformed by pol-oma virus.

Authors:  Y Ito; J R Brocklehurst; R Dulbecco
Journal:  Proc Natl Acad Sci U S A       Date:  1977-10       Impact factor: 11.205

View more
  24 in total

Review 1.  Natural biology of polyomavirus middle T antigen.

Authors:  K A Gottlieb; L P Villarreal
Journal:  Microbiol Mol Biol Rev       Date:  2001-06       Impact factor: 11.056

2.  Characterization of the interaction of polyomavirus middle T antigen with type 2A protein phosphatase.

Authors:  E T Ulug; A J Cartwright; S A Courtneidge
Journal:  J Virol       Date:  1992-03       Impact factor: 5.103

3.  Functional asymmetry of the regions juxtaposed to the membrane-binding sequence of polyomavirus middle T antigen.

Authors:  J Dahl; U Thathamangalam; R Freund; T L Benjamin
Journal:  Mol Cell Biol       Date:  1992-11       Impact factor: 4.272

4.  Interactions between polyomavirus medium T antigen and three cellular proteins of 88, 61, and 37 kilodaltons.

Authors:  T Grussenmeyer; A Carbone-Wiley; K H Scheidtmann; G Walter
Journal:  J Virol       Date:  1987-12       Impact factor: 5.103

5.  Development of an effective polyvalent vaccine against both Marek's and Newcastle diseases based on recombinant Marek's disease virus type 1 in commercial chickens with maternal antibodies.

Authors:  K Sonoda; M Sakaguchi; H Okamura; K Yokogawa; E Tokunaga; S Tokiyoshi; Y Kawaguchi; K Hirai
Journal:  J Virol       Date:  2000-04       Impact factor: 5.103

6.  12-O-tetradecanoylphorbol-13-acetate stimulates phosphorylation of the 58,000-Mr form of polyomavirus middle T antigen in vivo: implications for a possible role of protein kinase C in middle T function.

Authors:  J T Matthews; T L Benjamin
Journal:  J Virol       Date:  1986-05       Impact factor: 5.103

Review 7.  Lessons in signaling and tumorigenesis from polyomavirus middle T antigen.

Authors:  Michele M Fluck; Brian S Schaffhausen
Journal:  Microbiol Mol Biol Rev       Date:  2009-09       Impact factor: 11.056

8.  The amino terminus of polyomavirus middle T antigen is required for transformation.

Authors:  D N Cook; J A Hassell
Journal:  J Virol       Date:  1990-05       Impact factor: 5.103

9.  Multimerization of polyomavirus middle-T antigen.

Authors:  M Senften; S Dilworth; K Ballmer-Hofer
Journal:  J Virol       Date:  1997-09       Impact factor: 5.103

10.  Significance of the gastrin homology and surrounding sequences in polyomavirus middle T antigen for cell transformation.

Authors:  K L Clark; W R Folk
Journal:  J Virol       Date:  1986-01       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.